Drug Shortage Report for VISIPAQUE 270

Last updated on 2021-09-09 History
Report ID 145158
Drug Identification Number 02145766
Brand name VISIPAQUE 270
Common or Proper name Iodixanol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IODIXANOL
Strength(s) 550MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS
Packaging size 50 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-09-03
Actual start date 2021-09-03
Estimated end date 2021-09-09
Actual end date 2021-09-08
Shortage status Resolved
Updated date 2021-09-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-09-03 English Compare
v2 2021-09-03 French Compare
v3 2021-09-04 English Compare
v4 2021-09-08 English Compare
v5 2021-09-08 French Compare
v6 2021-09-09 English Compare

Showing 1 to 6 of 6